WX [WuXi PharmaTech (Cayman)] S-8: (Original Filing)

[] [WUXI PHARMATECH (CAYMAN) INC. 2007 EMPLOYEE SHARE INCENTIVE PLAN 1. PURPOSE OF PLAN Plan Company The purpose of this WuXi PharmaTech (Cayman) Inc. 2007 Employee Share Incentive Plan (this “ 2. ELIGIBILITY Eligible Person Securities Act participant Subsidiary The Administrator (as such term is defined in Section 3.1) may grant awards under this Plan only to those persons that the] [WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone July. 30, 2012 Shanghai 200131 People’s Republic of China Dear Sirs, WuXi PharmaTech (Cayman) Inc. (the “Company”) Registration Statement” Act Shares” Plan We have been asked to render this opinion in our capacity as counsel as to Cayman Islands law to the Company in connection with the Registration] [MAPLES and CALDER CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc. and the effectiveness of WuXi PharmaTech (Cayman) Inc.’s internal control over financial reporting dated April 20, 2012, appearing in]

By | 2016-04-02T17:38:24+00:00 July 30th, 2012|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] S-8:

[] [WUXI PHARMATECH (CAYMAN) INC. 2007 EMPLOYEE SHARE INCENTIVE PLAN 1. PURPOSE OF PLAN Plan Company The purpose of this WuXi PharmaTech (Cayman) Inc. 2007 Employee Share Incentive Plan (this “ 2. ELIGIBILITY Eligible Person Securities Act participant Subsidiary The Administrator (as such term is defined in Section 3.1) may grant awards under this Plan only to those persons that the] [WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone July. 30, 2012 Shanghai 200131 People’s Republic of China Dear Sirs, WuXi PharmaTech (Cayman) Inc. (the “Company”) Registration Statement” Act Shares” Plan We have been asked to render this opinion in our capacity as counsel as to Cayman Islands law to the Company in connection with the Registration] [MAPLES and CALDER CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc. and the effectiveness of WuXi PharmaTech (Cayman) Inc.’s internal control over financial reporting dated April 20, 2012, appearing in]

By | 2016-04-02T17:39:21+00:00 July 30th, 2012|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] 20-F: TABLE OF CONTENTS [TO BE UPDATED] Page INTRODUCTION

[TABLE OF CONTENTS [TO BE UPDATED] Page INTRODUCTION 1 2 PART I. ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 26 ITEM 4A. UNRESOLVED STAFF COMMENTS 44 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 44 ITEM 6. DIRECTORS,] [LIST OF SUBSIDIARIES • WuXi AppTec (BVI) Inc., incorporated in British Virgin Islands; • WuXi AppTec Co., Ltd., incorporated in People’s Republic of China (“PRC”); • WuXi AppTec (Shanghai) Co., Ltd., incorporated in PRC; • Shanghai SynTheAll PharmaTech Co., Ltd., incorporated in PRC; • WuXi AppTec (Suzhou) Co., Ltd., incorporated in PRC; • WuXi AppTec (Tianjin) Co., Ltd. , incorporated] [Certification by the Chief Executive Officer I, Ge Li, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Certification by the Chief Financial Officer I, Edward Hu, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Section 906 of the Sarbanes-Oxley Act of 2002 Ge Li Chief Executive Officer] [Certification by the Chief Financial Officer Edward Hu Chief Financial Officer] [April 20, 2012 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People’s Republic of China RE: WUXI PHARMATECH (CAYMAN) INC. Dear Sirs/Madams, Company We have acted as legal advisors as to the laws of the People’s Republic of China to WuXi PharmaTech (Cayman) Inc., an exempted limited liability company incorporated in the Cayman Islands] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-146730 on Form S-8 and Registration Statement No. 333-161757 on Form F-3 of our reports dated April 20, 2012, relating to the consolidated financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc. and its subsidiaries, and the effectiveness of WuXi]

By | 2016-04-02T17:45:10+00:00 April 20th, 2012|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)

[securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. (Continued on the Following Pages) 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kylin Fund LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ]]

By | 2016-04-02T17:51:54+00:00 February 14th, 2012|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Skip to toolbar